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162Introduction: Evaluating and comparing the success of surgical ablation techniques in the treatment of atrial
fibrillation is complicated by clinicians’ use of varying techniques to measure the burden of atrial fibrillation
after ablation. Intuitively, one would expect longer monitoring to be more accurate, picking up atrial fibrillation
events occurring at a low rate, but how long is long enough? This study compared rates of normal sinus rhythm
recorded after atrial fibrillation ablation in a cohort of patients monitored for a range of durations.
Methods: Two hundred fifty-four patients (50.4% paroxysmal) underwent surgical ablation for treatment of
atrial fibrillation. All patients were monitored at 6 months with both electrocardiography and either an event
monitor or implanted pacemaker device that could be interrogated. Event monitoring and pacemaker data
were analyzed for rhythm at 24 hours, 7 days, and 14 days; pacemaker data were also analyzed at 3 months.
Results: In the overall group, we found that rates of normal sinus rhythm detected were greatest with electro-
cardiography (91.7%) and decreased significantly at each of the longer durations (88.2% at 24 hours, 82.7% at
7 days, 81.1% at 14 days). Pacemaker data from a subset of patients revealed minimal or no statistically signif-
icant changes from 7 days to 3 months. Results were consistent across types of atrial fibrillation.
Conclusions: These findings suggest that rhythm measurements in patients with atrial fibrillation differ accord-
ing to the measurement duration used. We recommend longer-term monitoring, with 7 days providing both good
accuracy and good patient compliance. (J Thorac Cardiovasc Surg 2011;142:162-5)Atrial fibrillation (AF) is a common condition that affects
approximately 2 million people in the United States and is
increasing in prevalence as the population ages.1 During
the last several decades, catheter and surgical ablation tech-
niques for the treatment of AF have evolved rapidly, but
a consistent definition of successful ablation and the clinical
end points that constitute a successful ablation have been
lacking, as has an analysis of the various methods used to
monitor success.
In 2003, the US Food and Drug Administration recom-
mended ‘‘freedom from symptomatic atrial fibrillation at
one year’’ in end point analysis of clinical studies on cath-
eter ablation of AF (www.fda.gov/cdrh/ode/guidance/1229.
pdf). Monitoring for symptoms in patients with AF is both
unreliable, because 50% of recurrences occur in patients
without symptoms,2 and inaccurate, because symptoms
are over reported,3 with only 52% of patient symptoms
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The Journal of Thoracic and Cardiovascular SurgThe Heart Rhythm Society Task Force produced a con-
sensus statement that is the current standard, defining an
occurrence as any episode of AF, flutter, or tachycardia
with a duration of 30 seconds or longer.8 Even though
some research suggests that such 30-second episodes are
relatively common,9 the consensus statement does provide
the currently accepted and agreed definition of success.
Another problem is defining acceptable monitoring and
surveillance standards for AF. The Task Force recommends
24-hour Holter monitoring as an acceptable minimal mon-
itoring strategy for patients in a clinical trial. The consensus
statement does not, however, justify why the specific 24-
hour monitor duration was recommended. In comparison
studies, ‘‘snapshot’’ (30-second) and 24-hour electrocardio-
grams (ECGs) with 7-day event recording10.11; ECG with
5-day monitoring12; and 24-hour, 7-day, and 30-day simu-
lated intermittent monitoring with continuous pacemaker
readings13 have all been shown to have poor agreement.
Piorkowski and colleagues14 have argued that continuous
monitoring is superior to snapshot monitoring because of
the risk of missing asymptomatic episodes.
Despite these obvious discrepancies, no study to date
has compared the results of different monitoring dura-
tions in the same patient population. The objective of
this study was to compare the accuracy of snapshot
ECG with those of various intervals of long-term moni-
toring for patients who had undergone surgical ablation
for the treatment of paroxysmal, persistent, or long-
standing persistent AF.ery c July 2011
TABLE 1. Patient demographic and operative characteristics
Characteristic Value
No. of patients 254
Age (y)
Mean  SD 64.9  11.4
Median 65.0
Male (%) 61.0 (155/254)
Atrial fibrillation>12 mo (%) 89.8 (176/196)
Stand-alone ablation (%) 42.5 (108/254)
On-pump procedure (%) 54.8 (138/252)
Energy source (%)
Radiofrequency 61.8 (155/251)
Cryothermia 20.7 (52/251)
High-intensity focused ultrasound 14.7 (37/251)
Microwave 2.8 (7/251)
Type of atrial fibrillation before ablation (%)
Paroxysmal 50.4 (128/254)
Persistent 13.8 (35/254)
Long-standing persistent 35.8 (91/254)
Pulmonary vein isolation procedure (%) 100 (254/254)
Left atrial appendage removed (%) 85.0 (142/167)
Left atrial size (cm)
Mean  SD 4.9  1.1
Median 4.9
Ejection fraction (%)
Mean  SD 50.6  12.7
Median 50.0
Abbreviations and Acronyms
AF ¼ atrial fibrillation
ECG ¼ electrocardiogram
NSR ¼ normal sinus rhythm
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Data were extracted from our Society of Thoracic Surgeons customized
AF database for all patients who (1) underwent surgical ablation between
January 2004 and June 2009, (2) had at least 6 months of follow-up, and
(3) had both a snapshot ECG and long-termmonitoring (14-day event mon-
itor, or pacemaker interrogation) at 6 months after the AF ablation. The
event monitors were a mixture of devices provided by Medicomp (Medi-
comp, Inc, Melbourne, Fla) or CardioNet (Conshohocken, Pa). These
were autocapture devices that required no activation by the patient.
Patients undergoing ablation either stand-alone or with concomitant
procedures were eligible for the study. A total of 254 patients met the
criteria. The ablations were carried out with a variety of energy sources,
including cryothermia, focused ultrasound, microwave, and bipolar or
unipolar radiofrequency.
The study was approved by the North Texas Institutional Review Board
at Medical City with an exemption of consent.
Starting at the time of their 6-month office follow-up visit, all patients
were monitored for 14 days with an event monitor. Data were collected
and then used to analyze the rhythm in the first 24 hours, first 7 days,
and full 14 days of monitoring. Patients with pacemakers also provided
data for the whole 3-month period until next reset. Office ECGs were
performed at the visit.
All data were analyzed with SAS version 9.2 statistical software (SAS
Institute, Inc, Cary, NC). Means, SDs, and medians were calculated for
continuous variables. Categoric variables were analyzed with c2 statistics.
The comparisons of the different monitoring periods were subjected to the
McNemar test for discordant pairs. The McNemar test is a c2 test for
within-subject populations; in this case, the same patients were being
measured by multiple methods.P
MRESULTS
The demographic characteristics, types of AF, ablation
procedures, and energy sources used are shown in Table 1.
Figure 1 shows the percentages of patients who were re-
corded as being in normal sinus rhythm (NSR) at each of the
monitoring periods. As expected, increasing the monitoring
period detected more of the infrequent occurrences of AF.
Statistical comparisons of the numbers of patients recorded
as being in NSR showed statistically significant changes as
the period of monitoring was increased from snapshot ECG
to 14 days. The change achieved by monitoring past 7 days
was small (1.6%), however, suggesting little improvement
in accuracy with the extra time.
Subset analysis was carried out on data from 56 patients
who had implanted pacemakers allowing data recording for
3-month periods. Figure 2 shows the NSR percentages out
to 3 months of monitoring in that group of patients. These
data showed similar decreases in the percentage of patients
reported as being in NSR as the monitoring period in-
creased. In the pacemaker group, analysis shows that afterThe Journal of Thoracic and Ca7 days, there was a minimal change in the number of pa-
tients reported as being in NSR. The 14-day data detected
the same patients as at 7 days; extending the patient moni-
toring to 3 months did pick up a few more cases of AF, but
there was no statistically significant difference relative to
either 7 or 14 days.
Figure 3 presents the results when looking only at
patients who had paroxysmal AF at the time of ablation.
Further monitoring past 7 days picked up a small number
of new patients with continuing AF.
Figure 4 reports the data for 126 patients with persistent
or long-standing persistent AF. The data again show that
monitoring for longer than 7 days turned up few extra cases.
Subset analysis of the data captured from 24 patients with
paroxysmal AF who also had implanted pacemakers
showed 75.0% of them to be in NSR at 7 and 14 days of
monitoring, whereas the pacemaker data from 3 months
showed the rate slightly decreased, to 79.8% (P ¼ .317).
Among the 32 patients with pacemakers, all of whom
originally had the diagnosis of either persistent or long-
standing persistent AF, the pacemaker data showed equal
rates of 78.1% at 7 and 14 days, with a decrease to
71.9% at 3 months (P ¼ .157).DISCUSSION
The objective of this study was to determine the accura-
cies of various durations of monitoring needed to confirmrdiovascular Surgery c Volume 142, Number 1 163
FIGURE 1. Percentages of all patients scored as being in normal sinus
rhythm (NSR) at differing monitoring durations. ECG, In-office snapshot
electrocardiogram.
FIGURE 3. Percentages of all patients with preoperative paroxysmal
atrial fibrillation scored as being in normal sinus rhythm (NSR) at differing
monitoring durations. ECG, In-office snapshot electrocardiogram.
Perioperative Management Edgerton et al
P
Mpostablation success in patients who had undergone surgical
ablation for the treatment of AF. These patients had widely
differing operative techniques, but neither the technique nor
the absolute success rate is germane to this study. Accurate
identification of patients with recurrent AF is critical, be-
cause such patients may need to undergo further treatment,
including anticoagulation therapy to reduce the risk of
stroke.13,15
Consistent with the results of previous research,10-12 our
data show that snapshot ECG underestimates the true rate
of AF episodes after ablation. In-office snapshot ECG re-
sulted in the highest rates of ablation successwhen compared
with, 24-hour, 7-day, and 14-day monitoring in all cases.
Monitoring for longer than 7 days increased the accuracy
slightly, but the change relative to the 7 days data was gener-
ally not significant.FIGURE 2. Percentages of patients with implanted pacemakers (PPM)
scored as being in normal sinus rhythm (NSR) at differing monitoring
durations. ECG, In-office snapshot electrocardiogram.
164 The Journal of Thoracic and Cardiovascular SurgMonitoring for 3 months (only practical for patients with
implanted pacemakers) did not increase accuracy relative to
monitoring for 2 weeks, detecting few extra patients with
AF. This finding suggests that prolonged monitoring with
either external or implantable devices is not necessary.
When patient subgroups are analyzed according to preop-
erative type of AF, there was no change in the results. Al-
though one might expect that patients with long-standing
persistent AF would require shorter monitoring periods to
determine failure, this is not true. The explanation lies in
the fact that when these patients have failure of ablation,
the new disorder most often is paroxysmal AF, rather than
persistent AF.
These findings call into question the recommendation of
the Heart Rhythm Society Task Force on Catheter and Sur-
gical Ablation of Atrial Fibrillation, which states that forFIGURE 4. Percentages of all patients with preoperative persistent or
long-standing persistent atrial fibrillation scored as being in normal sinus
rhythm (NSR) at differing monitoring durations. ECG, In-office snapshot
electrocardiogram.
ery c July 2011
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Mpatients in a clinical trial, 24-hour Holter monitoring should
be considered an acceptable minimal monitoring strategy.8
The percentage of patients reported as being in NSR was
found to be significantly higher with 24-hour monitoring
than with any of the longer monitoring intervals measured
here (7 days, 14 days, or 3 months). Our findings thus sug-
gest that clinical studies and treatment strategies that rely on
24-hour monitoring are likely to overestimate freedom from
AF recurrence.11,13
Among the patients in this study, 7-day monitoring pro-
vided a more accurate determination of ablation success
than did 24-hour monitoring. The 7-day monitoring period
consistently differed from the shorter capture durations and
yet did not differ substantially from the longer intervals
studied. Furthermore, patient compliance with use of exter-
nal devices tends to decrease as the monitoring period
increases,5 and cost charges for external devices are fre-
quently based on the length of time the device is in use by
the patient. Economic considerations such as this may be
damaging to a patient’s willingness to undergo long periods
of monitoring. This suggests that 7-daymonitoring provides
the best compromise for achieving accurate and consistent
outcomes measurement in patients with AF who have
undergone surgical ablation.14
Study Limitations
The major limitation of the study is that the event moni-
tors used measured any AF that lasted longer than 15 sec-
onds as an event. Given that the Heart Rhythm Society
guidelines call for events to last at least 30 seconds, these
event monitors will have overreported by an unknown
amount. Pacemakers, in contrast, accurately reported the
durations of all events.
CONCLUSIONS
Our findings demonstrate the potential inaccuracy of both
snapshot ECG and 24-hour monitoring to detect AF recur-
rence in patients who have undergone surgical ablation, de-
spite the recommendation of the shorter 24-hour Holter
monitor in the Task Force guidelines. Future research is re-
quired to support the development of a consistent definition
of ablation success. It is clear from this study, however, that
developed guidelines should incorporate longer monitoring
durations, with 7 days the likely best compromise. It is
appropriate to reexamine the recommendations of theThe Journal of Thoracic and Caconsensus statement. Future published studies examining
the success of catheter or surgical ablation should monitor
patients for a minimum of 7 days.
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